Clinical Trials Management System (CTMS) “OnCore”

Jan 4, 2021 | Conduits News

ConduITS the Clinical & Translational Science Award at Mount Sinai received an administrative supplement from NCATS the NIH center that funds the CTSA program in August of 2018 to implement a system-wide Clinical Trials Management System (CTMS) “OnCore”. The Office of Research Services (ORS) within ConduITs is implementing the CTMS. OnCore will standardize clinical research (C/R) oversight in research compliance, billing and the conduct of C/R trials, allow institution-wide reporting of C/R metrics, and centralize access to the ISMMS research portfolio improving the management of Clinical Trials conducted at the Mount Sinai Health System.

In March of 2020, the enterprise roll-out of OnCore CTMS was put on hold due to the COVID-19 pandemic as most study personnel were deployed to assist with the pandemic as non-essential research was put on hold. ORS pivoted the focus of the system-wide implementation toward the use of OnCore to manage COIVD-19 clinical trials. This allowed the ORS to enhance the management of the COVID-19 Protocol Review Committee and disseminate a list of active COVID-19 clinical trials to clinicians across the health system. The ORS is currently working with the Epic team to develop a report of patients enrolled in COVID-19 to reduce redundancies in matching eligible patients to active studies.

The ORS also used the time to develop enhanced and remote e-learning and training resources for OnCore. With the help of Levy Library, the OnCore CTMS End-User Training eLearning Modules were created using the software Camtasia and were tailored to the Mount Sinai research community. As we adjusted to the “new normal”, these eLearning modules expedited the process of training new users. This allowed study teams adjusting to different schedules and working remotely to have access to the training resources at any time.

In late August when the enterprise roll-out resumed, the eLearning Modules became a pre-requisite for teams to complete prior to Go-Live Training conducted via Zoom. Prior to the development of the eLearning modules, Go-Live Training would typically take an entire work day, but has now has turned into a 2 ½ hour live training session. In addition to the resumption of the enterprise roll-out of OnCore CTMS, ORS has begun the process of collaborating with the Tisch Cancer Institute by assisting with the Clinical Research Coordinator Training in OnCore CTMS.

Anticipated date of completion of the enterprise roll-out is May 2021.

The OnCore CTMS End-User Training eLearning Modules are expected to be available in PEAK by December of 2021.

If you have any questions or want to read about updates to the OnCore role out contact Research411 or go to The Research Roadmap.

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

 

 

 

Recent ConduITS News

Introduction to the Research Roadmap

Who Should Use the Research Roadmap at Mount Sinai? Researchers, research teams, and trainees within the Mount Sinai Health System (MSHS), including any research professional at the Icahn School of Medicine at Mount Sinai (ISMMS).  What is the Research Roadmap? The...

read more

Introduction to ResearchMatch

What is ResearchMatch? ResearchMatch is a nonprofit, online recruitment platform designed to connect researchers with volunteers interested in participating in health-related research studies. It allows researchers to efficiently find eligible participants while...

read more

Introduction to Oncore

OnCore is Mount Sinai’s Clinical Trials Management System (CTMS), that is designed to support the full lifecycle of research studies. It helps teams manage protocols, track enrollment and oversee finances —all through integrated tools and automated workflows.  Mount...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Dr. Lee 2025 KL2 Scholar

Dr. Lee 2025 KL2 Scholar

Dr. Lee is an Assistant Professor in the Division of Surgical Oncology. Her proposal is titled ‘Generating a Multimodal Machine Learning Model for Prediction of Thyroid Cancer Recurrence’. Her mentors will be: Girish Nadkarni, MD, MPH, Michael Marin, MD, and Gerald...

read more
Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi is an Assistant Professor in the Department of Immunology and Immunotherapy. His proposal is titled ‘Nanoparticle STING Immunotherapy Against TP53-Mutated Acute Myeloid Leukemia’. His mentors will be: Brian Brown, PhD, and Joshua Brody, MD.  Dr. Xiaoqi is...

read more